These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9467629)

  • 41. Efficiency of prostacyclin in the treatment of protamine-mediated right ventricular failure and acute pulmonary hypertension.
    Ocal A; Kiriş I; Erdinç M; Peker O; Yavuz T; Ibrişim E
    Tohoku J Exp Med; 2005 Sep; 207(1):51-8. PubMed ID: 16082155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular effects of protamine sulfate in man.
    Shapira N; Schaff HV; Piehler JM; White RD; Still JC; Pluth JR
    J Thorac Cardiovasc Surg; 1982 Oct; 84(4):505-14. PubMed ID: 7121041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.
    Lowenstein E; Johnston WE; Lappas DG; D'Ambra MN; Schneider RC; Daggett WM; Akins CW; Philbin DM
    Anesthesiology; 1983 Nov; 59(5):470-3. PubMed ID: 6638558
    [No Abstract]   [Full Text] [Related]  

  • 44. Protamine Administration Via the Ascending Aorta May Prevent Cardiopulmonary Instability.
    Chaney MA; Devin Roberts J; Wroblewski K; Shahul S; Gaudet R; Jeevanandam V
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):647-55. PubMed ID: 26948466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement (C3, C4) consumption in cardiopulmonary bypass, cardioplegia, and protamine administration.
    Chiu RC; Samson R
    Ann Thorac Surg; 1984 Mar; 37(3):229-32. PubMed ID: 6703805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary microvascular responses to protamine and histamine. Effects of cardiopulmonary bypass.
    Friedman M; Johnson RG; Wang SY; Dai HB; Thurer RL; Weintraub RM; Sellke FW
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1092-9. PubMed ID: 7983878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass.
    Miles LF; Marchiori P; Falter F
    Perfusion; 2017 Sep; 32(6):481-488. PubMed ID: 28820026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of protamine-induced catastrophic pulmonary vasoconstriction by prostaglandin E1.
    Whitman GJ; Martel D; Weiss M; Pochanapring A; See WM; Hopeman A; Harken AH; Dauber IM
    Ann Thorac Surg; 1990 Aug; 50(2):303-5. PubMed ID: 2383122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effectiveness of preventing hypotension with H1/H2 antagonists before protamine administration].
    Behne M; Bremerich D; Schiesser S; Asskali F
    Infusionsther Transfusionsmed; 1994 Apr; 21(2):81-5. PubMed ID: 7517238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement activation and anaphylactoid response to protamine in a child after cardiopulmonary bypass.
    Westaby S; Turner MW; Stark J
    Br Heart J; 1985 May; 53(5):574-6. PubMed ID: 3994875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [About severe shock after protamine infusion in a neonate undergoing cardiopulmonary bypass].
    Ponvert C
    Ann Fr Anesth Reanim; 2014 Jan; 33(1):48-9. PubMed ID: 24378040
    [No Abstract]   [Full Text] [Related]  

  • 52. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
    Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
    Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of twice catastrophic pulmonary vasoconstriction-type shock induced with protamine sulfate].
    Inoue S; Miyashita T; Kuro M
    Masui; 1997 Jul; 46(7):987-90. PubMed ID: 9251520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absence of complement-mediated events after protamine reversal of heparin anticoagulation.
    Wakefield TW; Kirsh MM; Till GO; Brothers TE; Hantler CB; Stanley JC
    J Surg Res; 1991 Jul; 51(1):72-6. PubMed ID: 2067362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Complications caused by protamine. 2. Therapy and prevention].
    Hobbhahn J; Habazettl H; Conzen P; Peter K
    Anaesthesist; 1991 Aug; 40(8):421-8. PubMed ID: 1952034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protamine-induced fatal anaphylaxis. Prevalence of antiprotamine immunoglobulin E antibody.
    Sharath MD; Metzger WJ; Richerson HB; Scupham RK; Meng RL; Ginsberg BH; Weiler JM
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):86-90. PubMed ID: 3892171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A case of anaphylactic shock in an elderly man following protamine sulfate administration during emergent off-pump coronary artery bypass grafting].
    Kudoh O; Warabi K; Yamaguchi K; Ichinose M; Iizuka T; Inada E
    Masui; 2006 May; 55(5):605-10. PubMed ID: 16715917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.